Introduction
============

Computed tomography (CT) scan-guided biopsy of thoracic lesions is a widely accepted diagnostic technique.[@b1-ccrpm-2010-009] Previously, CT scan-guided biopsies were usually performed with fine-needle aspiration and cytological examination to differentiate malignant from benign lesions.[@b2-ccrpm-2010-009],[@b3-ccrpm-2010-009] A further development is tissue core biopsy using a cutting needle; this allows histopathological evaluation of the specimen.[@b4-ccrpm-2010-009] An automated spring-driven cutting needle for tissuecore biopsy has made it easier to obtain satisfactory specimens for histological analysis.[@b5-ccrpm-2010-009]--[@b7-ccrpm-2010-009] Percutaneous transthoracic biopsy is now more widely performed with helical CT-scanning;[@b2-ccrpm-2010-009] however, there are other modalities employed for this imaging guided procedure such as fluoroscopy and conventional CT-scanning.[@b1-ccrpm-2010-009]--[@b3-ccrpm-2010-009]

We are unaware of reports in the literature dealing with the number of biopsies in pulmonary lesions required for an accurate histological work up. Therefore, the purpose of our study was to analyse, whether the number of biopsy specimen taken has an impact on diagnostic accuracy at histologic examination.

Materials and Methods
=====================

Subjects
--------

From January 1999 to April 2004, 260 patients (mean age of the patients was 64.3 years (range 35--82 years; 158 men and 102 women)) with pulmonary lesions underwent CT-guided core-cut biopsy at our institution. Overall, 669 biopsies were obtained, 1--5 biopsies from each patient at the radiologists's discretion. None of the patients had severe chronic obstructive disease (COPD), severe emphysema or a coagulopathy. All patients gave written informed consent.

Biopsy Needle
=============

Core-cut biopsy in coaxial technique was performed with a 20-gauge needle (Manan^®^ biopsy needle, Gainsville Florida). The Auto Surecut system (Pro Mag 2.2 Manan^®^) consists of an outer cutting cannula with a coring point and a trocar with a sharp tip. A closed microsyringe is attached to the outer cutting cannula inside the body of the cutting needle device. The outer cutting cannula is automatically extended to a length of 2.2 cm. At the same time, a vacuum is established in the biopsy canal; the tissue biopsy is obtained by negative pressure at the tip of the outer cannula.

Biopsy Procedure
================

Before undergoing biopsy all patients had diagnostic helical CT scans (Lightspeed GE, Wisconsin, USA) of the chest with 5 mm slice thickness. These preliminary images were reviewed to plan the level of the needle entry site, patient's position and the most direct approach for successful biopsy. Patients assumed a supine, prone or lateral position. Experienced interventional radiologists performed all biopsies.

An 19 gauge outer guiding cannula was always used to prevent the flexible 20-gauge needle from deviating into the soft tissue.

Core-cut biopsies were taken with the Auto Surecut system as described previously.

Informed consent was obtained from each patient at least 24 hours before the interventional procedure.

Statistics
==========

All statistical analyses were performed with the statistical software package SPSS version 10.0. The chi square test was applied to analyse dichotomous variables. Statistical significance was considered as *P* \< 0.05.

Results
=======

In 591 of 669 biopsies (88.3%), there were positive results that correlated with and ultimately were confirmed by subsequent surgery, clinical follow-up or autopsy. The accuracy was 87.4%. In 193 of 260 (74.2%) patients, a suspected malignancy was confirmed by surgery. The diagnosis of 13 patients of the surgical group was confirmed additionally by autopsy. In 50 of 260 (19.2%) patients, a benign lesion was correctly diagnosed. They had a follow up period of one year. At the end of one year a CT scan was performed. Seventeen (6.5%) patients were lost to follow-up. The first, second and third biopsies had cumulative accuracies of 63.6%, 89.2% and 91.5%, respectively (*P* \< 0.02) ([Fig. 1](#f1-ccrpm-2010-009){ref-type="fig"}). In [Figures 2](#f2-ccrpm-2010-009){ref-type="fig"} and [3](#f3-ccrpm-2010-009){ref-type="fig"} the number of patients and the number of biopsies that were performed are listed.

All histological results are summarized in [Figure 3](#f3-ccrpm-2010-009){ref-type="fig"}.

The median size of pulmonary nodules was 2.8 cm ± 14.9 (range 0.9--6.3 cm). The median lesion depth was 1.2 cm ± 1.4 (range 0--6 cm). Pneumothorax was the most frequent complication: 87 of 260 patients (33.4%) developed a pneumothorax but only 10 (3.8%) patients required a transthoracal chest tube to evacuate the pneumothorax. The second most frequent complication was haemoptysis in 12 (4.6%) patients, none of whom required any further interventional or surgical treatment ([Table 1](#t1-ccrpm-2010-009){ref-type="table"}). Otherwise, there were no serious adverse events.

Discussion
==========

Percutaneous biopsy of thoracic lesions has become established as an effective and safe procedure. Successful percutaneous needle biopsy of lung lesions has been applied with excellent results and few complications.[@b8-ccrpm-2010-009]--[@b10-ccrpm-2010-009] The key to these procedures is the imaging guidance, which allows for the safe passage of a needle into the region of interest in the lung. In most settings, percutaneous biopsy is the first approach to diagnosis.

There is little literature dealing with the question of the optimal number of biopsies that should be obtained for the highest possible accuracy, unless a pathologist is on site.

In 669 biopsies, we found that the highest possible accuracy was obtained with three suitable specimens. More biopsies did not have any further impact on diagnostic accuracy. We find it of consequence to obtain three specimens in one setting because the operator uses the same approach via the previously positioned outer cannula. More biopsies do not improve the accuracy in the histopathological work-up. A strong reason for this retrospective result cannot be addressed. One fact we stress is the prefabricated way for the multiple biopsies by the outer cannula. Furthermore we state, that there are different numbers of patients in the different biopsy groups which makes the data less comparable. Statistically, we found a strong indication, that at least three biopsies show the best result in terms of accuracy.

In our cohort, we observed a complication rate in terms of pneumothorax of 33.4%. Twelve patients needed further treatment with a transthoracal chest tube to evacuate the pneumothorax. Our results correlate quite well with the literature, in which the reported frequency of pneumothorax for CT-guided procedures varies from 8% to 64% ([Fig. 2](#f2-ccrpm-2010-009){ref-type="fig"}).[@b11-ccrpm-2010-009]--[@b15-ccrpm-2010-009] The median size of our pulmonary nodules was 2.8 cm ± 14.9 (range 0.9--6.3 cm) and the median lesion depth was 1.2 cm ± 1.4 (range 0--6 cm). A lesion size ≤ 2 cm, a lesion depth of 0.1 to 2 cm and less experienced radiologists are given as the strongest parameters predictive of pneumothorax. The highest bleeding risk correlates with a lesion size ≤ 2 cm, a lesion depth of \> 2.1 cm and the absence of pleural effusion.[@b16-ccrpm-2010-009] Finally, for the power of this study it is important to mention the multi---operative specimens obtaining.

The histological results of our cohort also correlate well with those in the literature.[@b17-ccrpm-2010-009] There is an important advantage to be mentioned in terms of patient's risks. Obtaining three specimens instead of four or five reduces the risk of bleeding and pneumothorax.

The limits of this study are not only the small patient number. The fact, that there a different numbers of patients in the different study groups makes a reliable statement on the absolute necessary number of core cut biopsies in lung lesions difficult. Therefore we stress the fact to design a lager prospective study with better comparable numbers of patients in the different study groups.

Nevertheless, we find that CT-guided core-cut biopsy of pulmonary nodules is an effective diagnostic tool for diagnosing pulmonary lesions. On the basis of our data a total number of at least three specimens for every CT-guided core-cut biopsy could be recommended on the condition that each core shows a well preserved barrel for histopathological work up. However, further prospective studies with a greater number of patients and a better distribution of the patients between the different biopsy groups will be helpful for the confirmation of this study data.
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###### 

Histological diagnosis of 260 patients with pulmonary lesions. Specimens obtained by CT-guided core-cut biopsy.

  **Histology**                                                   
  --------------------------------------------------------------- -------------
  Benign                                                          50 (19.2%)
    Harmatoma                                                     7
    Wegener's disease                                             2
    Sarckoidosis                                                  2
    Amyloidosis                                                   1
    Non-specific[\*](#tfn1-ccrpm-2010-009){ref-type="table-fn"}   38
  Lost to follow-up                                               0 (0%)
  Malignant                                                       193 (74.2%)
    Adenocarcinoma                                                85
    Non-small cell                                                23
    Squamous                                                      33
    Metastasis                                                    29
    Undifferentiated carcinoma                                    17
    BAC                                                           5
    Lymphoma                                                      1
  Lost to follow-up                                               17 (6.5%)

In the non-specific group no precise diagnosis was obtained by biopsy, but the benign nature of the lesion was confirmed during follow-up period.

###### 

Synopsis of complication rate in 260 patients undergoing CT-guided core-cut biopsy.

  **Complication**             
  ---------------------------- ------------
  Overall                      99 (38.1%)
  Pneumothorax                 87 (33.4%)
    Transthoracal chest tube   10 (3.8%)
  Haemoptysis                  12 (4.6%)
